MX9606388A - Formas truncadas de la proteina inhibidora kappa b (i kappa b alfa), produccion recombinante de dicha proteina y sus usos. - Google Patents

Formas truncadas de la proteina inhibidora kappa b (i kappa b alfa), produccion recombinante de dicha proteina y sus usos.

Info

Publication number
MX9606388A
MX9606388A MX9606388A MX9606388A MX9606388A MX 9606388 A MX9606388 A MX 9606388A MX 9606388 A MX9606388 A MX 9606388A MX 9606388 A MX9606388 A MX 9606388A MX 9606388 A MX9606388 A MX 9606388A
Authority
MX
Mexico
Prior art keywords
protein
ikb
recombinant production
truncated form
inhibitory kappa
Prior art date
Application number
MX9606388A
Other languages
English (en)
Other versions
MXPA96006388A (es
Inventor
Gary Allen Peltz
Paula Nanette Belloni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9606388A publication Critical patent/MX9606388A/es
Publication of MXPA96006388A publication Critical patent/MXPA96006388A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan formas truncadas de la proteína inhibidora kappa B (IkBalfa),ácidos nucleicos que codifican para las formas truncadas, vectores de expresion y transporte, y usos terapéuticos y profilácticos derivados.
MXPA/A/1996/006388A 1995-12-15 1996-12-13 Formas truncadas de la proteina inhibidora kappa b (i kappa b alfa), produccion recombinante de dicha proteina y sus usos MXPA96006388A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US008672 1979-02-02
US867295P 1995-12-15 1995-12-15
US3193596P 1996-11-26 1996-11-26
US031935 1996-11-26

Publications (2)

Publication Number Publication Date
MX9606388A true MX9606388A (es) 1998-05-31
MXPA96006388A MXPA96006388A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
EP0779361A2 (en) 1997-06-18
EP0779361A3 (en) 1999-11-10
BR9606023A (pt) 1998-09-08
AR004377A1 (es) 1998-11-04
CN1157828A (zh) 1997-08-27
TR199601006A2 (tr) 1997-07-21
TR199601006A3 (es) 1997-07-21
US6194175B1 (en) 2001-02-27

Similar Documents

Publication Publication Date Title
PL308122A1 (en) Viral vectors and their application in genic therapy
EP0723555A4 (en) CHEMICAL PROTEINS WITH BLOCK SUPPLEMENT ACTIVATION
HUP9902310A2 (hu) Komplementer adenovírus-vektorrendszerek és sejtvonalak
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
HU9603155D0 (en) Papillomavirus vaccines
DE69331484D1 (de) N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür
EP0670895A4 (en) CLONING, EXPRESSION AND USES OF A NEW SECRETIED PROTEIN, F-SPONDIN.
EP0833912A4 (en) NEW TRANSFORMING GROWTH FACTOR TYPE CYTOKINE TGF-BETA
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
ATE397062T1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
IL115432A0 (en) Viral vectors and their uses in gene therapy
TR199601006A2 (tr) Engelleyici kappa proteinin (I,B) kesik formlari, rekombinant üretimi ve bunlarin kullanimi.
NO964431D0 (no) Ikke-spleisende varianter av gp350/220
AU3118095A (en) Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
DE69631127D1 (en) Glykosyltransferase expression in aspergillus
DK0627004T3 (da) Forbedringer ved eller i forbindelse med malariavaccine
HUT50503A (en) Modificated proteines
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
AU2436095A (en) Cloning, expression, and uses of human lactoferrin
AU2705497A (en) Gene expression in monocytes and macrophages
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
EP0832972A3 (en) Cloning, expression and production of tasty peptides
ZA973029B (en) Expression of recombinant peptides.
AU1888095A (en) Human megakaryocytopoietin and isolation thereof, cdna cloning, and preparation of the recombinant protein